Progyny, Inc.

NasdaqGS PGNY

Progyny, Inc. Price to Book Ratio (P/B) on January 14, 2025: 3.39

Progyny, Inc. Price to Book Ratio (P/B) is 3.39 on January 14, 2025, a -52.25% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Progyny, Inc. 52-week high Price to Book Ratio (P/B) is 7.70 on February 12, 2024, which is 127.34% above the current Price to Book Ratio (P/B).
  • Progyny, Inc. 52-week low Price to Book Ratio (P/B) is 2.31 on November 19, 2024, which is -31.79% below the current Price to Book Ratio (P/B).
  • Progyny, Inc. average Price to Book Ratio (P/B) for the last 52 weeks is 4.59.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqGS: PGNY

Progyny, Inc.

CEO Mr. Peter Anevski CPA
IPO Date Oct. 25, 2019
Location United States
Headquarters 1359 Broadway
Employees 563
Sector Health Care
Industries
Description

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Similar companies

PRVA

Privia Health Group, Inc.

USD 21.00

1.25%

SLP

Simulations Plus, Inc.

USD 28.76

-0.48%

TDOC

Teladoc Health, Inc.

USD 9.36

-3.50%

EVH

Evolent Health, Inc.

USD 11.18

-9.77%

NRC

National Research Corporation

USD 16.93

-1.97%

CERT

Certara, Inc.

USD 10.74

-2.10%

DH

Definitive Healthcare Corp.

USD 3.92

-0.25%

PHR

Phreesia, Inc.

USD 26.12

-1.69%

HSTM

HealthStream, Inc.

USD 31.47

1.68%

GDRX

GoodRx Holdings, Inc.

USD 4.15

-1.66%

HCAT

Health Catalyst, Inc.

USD 5.90

-9.09%

VEEV

Veeva Systems Inc.

USD 210.86

-0.93%

TXG

10x Genomics, Inc.

USD 15.44

-1.72%

StockViz Staff

January 15, 2025

Any question? Send us an email